Richard M. faced a grim outlook on life when doctors diagnosed him with mesothelioma in 2012. He had one year to live. After undergoing an aggressive surgery, the Tennessee native turned to a targeted therapy clinical trial — and it worked. Now, he and his wife continue making the 100-mile trek to the ongoing clinical trial at the Sarah Cannon Research Institute in Nashville. The 60-year-old praises that clinical trial for extending his life expectancy beyond his initial prognosis.